Veradigm Overview
- Year Founded
-
1986

- Status
-
Public
- Employees
-
7,869

- Stock Symbol
-
MDRX

- Investments
-
38
- Share Price
-
$5.05
- (As of Tuesday Closing)
Veradigm General Information
Description
Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
Contact Information
Website
www.veradigm.comCorporate Office
- 222 Merchandise Mart Plaza
- Chicago, IL 60654
- United States
Corporate Office
- 222 Merchandise Mart Plaza
- Chicago, IL 60654
- United States
Veradigm Stock Performance
As of 18-Mar-2025, Veradigm’s stock price is $5.05. Its current market cap is $544M with 108M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$5.05 | $5.02 | $4.00 - $11.80 | $544M | 108M | 452K |
Veradigm Financials Summary
As of 31-Dec-2022, Veradigm has a trailing 12-month revenue of $588M.
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 1,653,552 | 1,653,552 | 2,506,791 | 3,089,130 |
Revenue | 588,000 | 588,000 | 1,503,037 | 1,502,700 |
EBITDA | (1,200) | (1,200) | 351,129 | 77,062 |
Net Income | (86,400) | (86,400) | 134,438 | 700,407 |
Total Assets | 1,504,700 | 1,504,700 | 2,425,229 | 2,917,618 |
Total Debt | 219,400 | 219,400 | 434,483 | 283,314 |
Veradigm Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Veradigm Comparisons
Industry
Financing
Details
Veradigm Competitors (70)
One of Veradigm’s 70 competitors is NextGen Healthcare, a Private Equity-Backed company based in Irvine, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NextGen Healthcare | Private Equity-Backed | Irvine, CA | ||||
TruBridge | Corporation | Mobile, AL | ||||
Napier Healthcare Solutions | Private Equity-Backed | Singapore, Singapore | ||||
Epic (Other Healthcare Technology Systems) | Private Equity-Backed | Verona, WI | ||||
Apixio | Private Equity-Backed | San Mateo, CA |
Veradigm Patents
Veradigm Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10375084-B2 | Methods and apparatuses for improved network communication using a message integrity secure token | Active | 31-Mar-2017 | ||
US-20180288068-A1 | Methods and apparatuses for improved network communication using a message integrity secure token | Active | 31-Mar-2017 | ||
US-20180288025-A1 | Methods and apparatuses for utilizing a gateway integration server to enhance application security | Active | 31-Mar-2017 | ||
US-10511574-B2 | Methods and apparatuses for utilizing a gateway integration server to enhance application security | Active | 31-Mar-2017 | ||
US-20170286207-A1 | Method and apparatus for improved error handling | Active | 31-Mar-2016 | G06F11/0793 |
Veradigm Signals
Veradigm Investments & Acquisitions (38)
Veradigm’s most recent deal was a Merger/Acquisition with ScienceIO. The deal was made on 27-Feb-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
ScienceIO | 27-Feb-2024 | Merger/Acquisition | Other Healthcare Technology Systems | ||
Koha Health | 02-Jan-2024 | Merger/Acquisition | Practice Management (Healthcare) | ||
Holmusk | 12-Oct-2023 | Later Stage VC | Enterprise Systems (Healthcare) | ||
Holmusk | 06-Jan-2023 | Later Stage VC | Enterprise Systems (Healthcare) | ||
Babel Health | 25-Mar-2022 | Merger/Acquisition | Business/Productivity Software |
Veradigm ESG
Risk Overview
Risk Rating
Updated October, 17, 2024
22.64 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile

Healthcare
Industry
of 581
Rank
Percentile

Health Care IT Services
Subindustry
of 34
Rank
Percentile

Veradigm Exits (9)
Veradigm’s most recent exit was on 28-Jun-2021 from Hospital IQ. The exit was categorized as with 4 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Hospital IQ | 28-Jun-2021 | Completed |
|
||
Conversa | 19-Jan-2021 | Completed |
|
||
Hospital IQ | 22-Oct-2018 | Completed |
|
||
OneContent | 02-Oct-2017 | Completed |
|
||
Careport | 14-Oct-2016 | Merger/Acquisition | Completed |
Veradigm Affiliates
Subsidiaries (3)
Name | Industry | Location | Year Founded |
---|---|---|---|
ScienceIO | New York, NY | 2019 | |
Practice Fusion | San Francisco, CA | 2005 | |
Koha Health | Merrimack, NH | 1983 |
Veradigm FAQs
-
When was Veradigm founded?
Veradigm was founded in 1986.
-
Where is Veradigm headquartered?
Veradigm is headquartered in Chicago, IL.
-
What is the size of Veradigm?
Veradigm has 7,869 total employees.
-
What industry is Veradigm in?
Veradigm’s primary industry is Enterprise Systems (Healthcare).
-
Is Veradigm a private or public company?
Veradigm is a Public company.
-
What is Veradigm’s stock symbol?
The ticker symbol for Veradigm is MDRX.
-
What is the current stock price of Veradigm?
As of 18-Mar-2025 the stock price of Veradigm is $5.05.
-
What is the current market cap of Veradigm?
The current market capitalization of Veradigm is $544M.
-
What is Veradigm’s current revenue?
The trailing twelve month revenue for Veradigm is $588M.
-
Who are Veradigm’s competitors?
NextGen Healthcare, TruBridge, Napier Healthcare Solutions, Epic (Other Healthcare Technology Systems), and Apixio are some of the 70 competitors of Veradigm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »